Here's the real deal on yesterdays surprising & welcome news right pug buddy!
VYST is on the cusp of officially completing their long awaited financial foundation with the filing of the Rotmans Super 8k and simultaneous insertion of the over +$30M fully audited Rotmans financials onto VYST's fully audited books!
And with VYST's official completion of their financial foundation directly ahead, comes the long awaited/anticipated full-fledged commercialization era on ALL the proprietary products in VYST's RxAir, FEC & Vytex pipelines!
And yesterdays totally unexpected news was just the 1st commercialization era table setting deal of many more coming over the near term horizon now. As the dividend spin off news is solely designed for VYST to extract fresh value out of 1 product out of 1 of their subsidiary divisions!
So anyone foolishly thinking that yesterdays news isn't relevant, or is supposedly hype, or is supposedly some fake dividend news that will never come to pass blah blah blah...is simply put, not even remotely paying attention to the real deal growth driving story VYST has spent this entire calendar year planning to roll out directly ahead!
And the simple fact is that VYST just found an amazingly creative way to unlock the inherent value in their UV 400 units from their RxAir subsidiary division by selling it to a soon to be named & revealed major healthcare manufacturer for an upfront investment of $3M to $5M, which sends a loud & clear message to market that VYST's BOD's know exactly how to get their pending commercialization era deals of consequence done with BIG FISH commercialization partners in whatever creative means possible!
And quite simply put, it's a great deal for VYST shareholders, because we get free shares in a brand new spin off company called RxAir Inc. sometime in December once VYST announces the ex-dividend date soon! And not only do we get free shares in the soon to be launched RxAir Inc. publicly trading spin off company by/b4 the end of this year. We already know that the new RxAir spinoff company is going to be majority control owned(51%) by a new major healthcare manufacturer that clearly believes they possess the capability & propensity to launch the UV 400 units and grow sales in a meaningful manner, otherwise they wouldn't be investing $3M to $5M in upfront monies to secure their 51% majority ownership control interests in the 1st place!
And again, that's 1 deal on 1 product on 1 subsidiary division! There's over +40,000 additional products in VYST's Vytex subsidiary division alone for VYST to secure similar dividend spin off deals in, or the more traditional royalty deals, joint ventures or licensing agreement deals most of us are expecting them to secure now that their long awaited optimal & immediately leverageable financial foundation is almost officially complete!
So the bottom line from here is that VYST just proved/showed in yesterdays table setting news that their BOD's is creative and savvy enough to convince BIG FISH commercialization era partners to get onboard with just 1 of the products in their vast stable of proprietary competitive advantage products. And the bonus to VYST shareholders is that the soon to be revealed healthcare manufacturer referenced in yesterdays news is definitely going to be growing UV 400 sales from the very moment they launch the new RxAir Inc. spin off company to kick off 2020! So the moment we get our dividend spin off shares the new commercialization era healthcare manufacturer BIG FISH partner is going to be in the very favorable position of making sure to grow the value of our RxAir Inc. spin off shares throughout all of next year, making VYST's very 1st commercialization era deal revealed in yesterdays table setting an extremely great deal for all their VYST shareholders who've been patiently waiting for VYST to begin the long awaited process of transitioning a multitude of final stage trials/talks into commercial scale partnerships of consequence, which is exactly what yesterdays news proves they're starting to do!
VYST is building & launching it, and much bigger boys are coming across the entire growth driving spectrum>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
News 
Market Data 
Discover 
